The report on global viral inactivation market is an in depth analysis of the segments and sub-segments in the viral inactivation market. The report provides analysis for the global as well as regional markets over the period of 2015 to 2023. According to report the global viral inactivation market is expected to grow at a CAGR of 10.9% over the forecast period of 2017 - 2023.

Figure 1: Global Viral Inactivation Market by Value 2015– 2023

Segments Covered

The report on global viral inactivation market covers segments such as method, product, application, and end user. The method segments include solvent detergent method, pasteurization and other methods. On the basis of product, the global viral inactivation market is categorized into kits and reagents, services and viral inactivation systems and accessories. Furthermore, on the basis of application the viral inactivation market is segmented as, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissues and tissue products, and stem cell products. On the basis of end user the viral inactivation market is segmented as pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.

Geographic Coverage

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.

Figure 2: Global Viral Inactivation Market by Region, CAGR %, 2015-2023

The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.

Companies Profiled:

The report provides profiles of the companies in the global viral inactivation market such as, Clean Cells Inc., Merck KGAA, Viral Inactivated Plasma Systems SA, Sartorius AG, Charles River Laboratories International, Inc., Rad Source Technologies, Inc., Wuxi Pharmatech (Cayman) Inc., Texcell, Inc., Parker Hannifin Corporation, and Danaher Corporation.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the Global Viral Inactivation Market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of Viral Inactivation Market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the Viral Inactivation Market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

This report will help manufacturers, suppliers and distributors of the Viral Inactivation Market to understand the present and future trends in this market and formulate their strategies accordingly.